Rare diseases
Investigational molecules
Locations
Back to Bulgaria437 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
BulgariaStudy of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer
BulgariaSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
BulgariaEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
BulgariaEfficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
BulgariaA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
BulgariaStudy of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab
BulgariaBulgariaTesting Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment
BulgariaA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
BulgariaA Study to Test How Safe Budoprutug Is and How Well It Works in Patients with Immune Thrombocytopenia
BulgariaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.
Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.
Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.
Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.
Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.
Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
